Atara Biotherapeutics, Inc.
NASDAQ:ATRABiotechnology
Healthcare
$6.77 +1.96%
+$0.19 today
- Market cap
- $68.98M
- Beta
- 0.11
- P/E (TTM)
- -14.7
- EPS (TTM)
- -$0.67
52W Low $3.92High $19.15
Volume 0.02M
Average 1.40M
Balance Sheet
Inspect the capital base behind the business.
Assets
$20.23M
FY 2025 · Annual
-81.5% YoYLiabilities
$58.74M
FY 2025 · Annual
-71.5% YoYEquity
-$38.50M
FY 2025 · Annual
Balance Sheet
USD
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 106.08M | 92.94M | 25.84M | 25.03M | 8.48M |
| Short-term Investments | 264.98M | 149.88M | 25.88M | 17.47M | 0 |
| Net Receivables | 986K | 40.22M | 34.11M | 1.48M | 1.25M |
| Inventory | 0 | 1.59M | 9.71M | 10.66M | 0 |
| Other Current Assets | 194K | 10.45M | 6.33M | 10.26M | 2.48M |
| Total Current Assets | 384.62M | 295.08M | 101.87M | 64.89M | 12.21M |
| Property, Plant & Equipment (Net) | 79.94M | 74.32M | 58.79M | 41.1M | 7.14M |
| Goodwill | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 |
| Long-term Investments | 0 | 0 | 0 | 0 | 0 |
| Tax Assets | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Assets | 3.57M | 7.02M | 4.84M | 3.1M | 886K |
| Total Non-current Assets | 83.51M | 81.34M | 63.64M | 44.2M | 8.02M |
| Total Assets | 468.13M | 376.42M | 165.5M | 109.1M | 20.24M |
| Account Payables | 17.37M | 6.87M | 3.68M | 4.37M | 127K |
| Short-term Debt | 0 | 0 | 0 | 0 | 10.78M |
| Tax Payables | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue | 40.76M | 8M | 77.83M | 95.09M | 716K |
| Other Current Liabilities | 25.15M | 32.75M | 37.01M | 6.59M | 2.03M |
| Total Current Liabilities | 105.79M | 78.92M | 142.23M | 134.57M | 14.92M |
| Long-term Debt | 0 | 0 | 0 | 0 | 32.67M |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Non-current) | 55.71M | 77M | 37.56M | 0 | 0 |
| Other Non-current Liabilities | 1.5M | 35.8M | 39.25M | 41.89M | 1.8M |
| Total Non-current Liabilities | 82.73M | 170.86M | 122.51M | 71.81M | 43.82M |
| Total Liabilities | 188.51M | 249.78M | 264.74M | 206.38M | 58.74M |
| Common Stock | 9K | 10K | 11K | 1K | 1K |
| Retained Earnings | (1.46B) | (1.69B) | (1.97B) | (2.05B) | (2.02B) |
| Accumulated OCI | (368K) | (2.07M) | (204K) | 8K | 1K |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Total Equity | 279.61M | 126.64M | (99.23M) | (97.28M) | (38.5M) |
| Total Debt | 28.27M | 71.7M | 57.87M | 43.83M | 52.8M |
| Net Debt | (77.81M) | (21.24M) | 32.03M | 18.8M | 44.32M |
Balance Sheet
Assets, liabilities & equity
| Cash & Equivalents | $8.4M |
| Other Current | $3.8M |
| Total Current Assets | $12.2M |
| PP&E (Net) | $6.9M |
| Other Non-current | $890.0K |
| Total Non-current Assets | $7.8M |
| Total Assets | $20.0M |
Analysis
Selected assets total $20.0M for Latest. The largest visible component is Cash & Equivalents at $8.4M, about 41.8% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.
Recent Filings
Recent regulatory filings
| Filing | Description | Date | |
|---|---|---|---|
| S-3 | S-3 filing | Nov 10, 2026 | |
| 8-K | Current report | Nov 10, 2026 | |
| 10-Q | Quarterly report | Nov 10, 2026 | |
| 4 | Statement of changes in beneficial ownership | Sep 4, 2026 | |
| 4 | Statement of changes in beneficial ownership | Aug 26, 2026 |
How much cash does ATRA have?
Atara Biotherapeutics, Inc. (ATRA) reported $8.48M in cash and equivalents in fiscal 2025.
How much debt does ATRA carry?
Atara Biotherapeutics, Inc. (ATRA) reported $52.80M of total debt, with net debt of $44.32M.
Continue the stock analysis
Jump to another research area for this company.